Word

ABRYTOP

Status

Pending

Status Code

731

Status Date

Tuesday, February 27, 2024

Serial Number

97348833

Mark Type

4000

Filing Date

Wednesday, April 6, 2022

Published for Opposition

Tuesday, November 1, 2022

Trademark Owner History

TEVA PHARMACEUTICALS USA, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations but not including vaccines or pharmaceuticals for the treatment of respiratory viruses, diseases, and disorders

ABRY TOP

Trademark Events

Feb 28, 2024

Notice Of Approval Of Extension Request E-Mailed

Feb 27, 2024

Sou Extension 2 Granted

Feb 27, 2024

Sou Extension 2 Filed

Feb 27, 2024

Sou Teas Extension Received

Aug 18, 2023

Notice Of Approval Of Extension Request E-Mailed

Aug 16, 2023

Sou Extension 1 Granted

Aug 16, 2023

Sou Extension 1 Filed

Aug 16, 2023

Sou Teas Extension Received

Feb 28, 2023

Noa E-Mailed - Sou Required From Applicant

Jan 13, 2023

Changes/Corrections After Pub Approval Entered

Jan 11, 2023

Extension Of Time To Oppose Process - Terminated

Jan 10, 2023

Assigned To Petition Staff

Dec 15, 2022

Post Publication Amendment Received

Dec 15, 2022

Teas Petition To Amend Basis Received

Nov 21, 2022

Extension Of Time To Oppose Received

Nov 1, 2022

Official Gazette Publication Confirmation E-Mailed

Nov 1, 2022

Published For Opposition

Oct 12, 2022

Notification Of Notice Of Publication E-Mailed

Sep 26, 2022

Approved For Pub - Principal Register

Sep 20, 2022

Assigned To Examiner

Apr 11, 2022

New Application Office Supplied Data Entered

Apr 9, 2022

New Application Entered